Bookmark

Add to MyYahoo RSS

Dey News

News on Dey (Ticker: MYL) continually updated from thousands of sources around the net.

Saturday Jul 26 | AmericanBankingNews.com

Mylan Lowered to Neutral at Citigroup Inc.

They currently have a $57.00 price objective on the stock, down from their previous price objective of $61.00.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Banking, Financial Services, Citigroup

Mon Jul 21, 2014

AmericanBankingNews.com

Mylan Given Consensus Rating of "Buy" by Brokerages

Mylan has been given a consensus recommendation of "Buy" by the fifteen brokerages that are presently covering the company, Analyst Ratings.Net reports .

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups

Seeking Alpha

Why Abbott's Stake In Mylan Will Be Value-Creative

Abbott has a track record that is unrivaled. The firm is more than 125 years old and remains aligned with favorable long-term healthcare trends in both developed and developing markets.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Thu Jul 17, 2014

Safehaven

Is It 1999 All Over Again?

Consider the following: In the energy sector, Kodiak Oil & Gas agreed to be acquired by Whiting Petroleum , resulting in a sizable jump for both stocks.

Comment?

Related Topix: Financial Markets, Construction, URS Corporation, Architecture, Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Benzinga

Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

Mylan Inc. today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to Paroxetine CR, the generic version of GSK's PaxilA CR.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, GlaxoSmithKline

Wed Jul 16, 2014

Investor's Business Daily

Treasury Urges Halt to Tax Inversion M&A 'Abuse'

In a letter to four members of the House Ways and Means Committee, Treasury Secretary Jacob Lew urged lawmakers to immediately enact legislation that will "shut down this abuse of our tax system" - and make it retroactive to May 2014.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, US News

Business Journal

Obama administration pushing for stop to international mergers with big tax savings

The Obama administration is exerting pressure to avert inversion deals, Bloomberg reported Wednesday, citing a letter Treasury Secretary Jacob Lew sent to Congress urging approval of tax changes retroactive to May. The aim is to stop U.S. corporations from using international mergers that give them substantial tax breaks.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups

Tue Jul 15, 2014

Seeking Alpha

Mylan - Much Anticipated Specialty And Branded Generics Deal With Abbott Is Finally A Reality

Mylan has announced a much anticipated deal under which it will acquire specialty and branded generic drugs from Abbott .

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Mon Jul 14, 2014

MarketNewsVideo

Nasdaq 100 Movers: VRTX, MYL

In early trading on Monday, shares of Mylan topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.8%.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Vertex Pharmaceuticals, Business News, Video

Freshnews

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty...

Mylan Inc. today announced that it has entered into a definitive agreement with Abbott whereby Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business in an all-stock transaction.

Comment?

Related Topix: Abbott Laboratories, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups

Fri Jul 11, 2014

Forbes.com

Paychex Becomes #6 Most Shorted Nasdaq 100 Component, Replacing Mylan

The most recent short interest data has been released by the NASDAQ for the 06/30/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover."

Comment?

Related Topix: Paychex, SurePayroll, Human Resources, Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Financial Markets

Tue Jul 08, 2014

BioSpace

Mylan Inc. Launches Generic Micardis?? Tablets

Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated for the treatment of hypertension, to lower blood pressure.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Micardis, Telmisartan (generic), Startups, Food and Drug Administration, Hypertension, Health

Mon Jul 07, 2014

AmericanBankingNews.com

Traders Buy Large Volume of Put Options on Mylan

Shares of Mylan saw some unusual options trading on Monday. Investors bought 2,541 put options on the company, ARN reports.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups

Tue Jul 01, 2014

Freshnews

Mylan Schedules Second Quarter 2014 Financial Results Conference Call ...

Mylan Inc. announced today that it will host a conference call and live webcast on Thursday, Aug. 7, 2014, at 10:00 a.m. ET to review the company's financial results for the second quarter and first half ended June 30, 2014.

Comment?

Related Topix: Mylan Laboratories, Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Startups

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••